Cline Christopher R.

Travere Therapeutics, Inc. ยท CHIEF FINANCIAL OFFICER

Cline Christopher R. is listed in public filings as officer: CHIEF FINANCIAL OFFICER. This Cline Christopher R. insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Travere Therapeutics, Inc. (TVTX). Investors use Cline Christopher R.'s insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Travere Therapeutics, Inc.TVTX$5.2M118.7k sharesSellMay 6, 2026$13.6K310 shares$43.95--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Travere Therapeutics, Inc.TVTX$5.5M119k sharesSellMay 5, 2026$101.7K2.2k shares$46.65--
Travere Therapeutics, Inc.TVTX--4.3k sharesGrant / ExerciseMay 4, 2026Disclosure amount unavailable4.3k shares----
Travere Therapeutics, Inc.TVTX--8.5k sharesGrant / ExerciseMay 4, 2026Disclosure amount unavailable8.5k shares----
Travere Therapeutics, Inc.TVTX$5.0M116.9k sharesSellApr 15, 2026$43.2K1k shares$42.61--
Travere Therapeutics, Inc.TVTX$4.9M117.9k sharesSellApr 14, 2026$303.5K7.2k shares$41.93--
Travere Therapeutics, Inc.TVTX$5.1M125.2k sharesSellApr 14, 2026$3709 shares$41.07--
Travere Therapeutics, Inc.TVTX$3.6M125.2k sharesSellApr 13, 2026$1.9K65 shares$28.85--
Travere Therapeutics, Inc.TVTX--125.2k sharesGrant / ExerciseApr 13, 2026Disclosure amount unavailable14k shares----
Travere Therapeutics, Inc.TVTX$3.7M111.2k sharesSellFeb 4, 2026$3.6K110 shares$32.90--
Travere Therapeutics, Inc.TVTX$3.6M111.3k sharesSellFeb 4, 2026$52.5K1.6k shares$32.14--
Travere Therapeutics, Inc.TVTX$3.6M113k sharesSellFeb 3, 2026$232.6K7.2k shares$32.12--
Travere Therapeutics, Inc.TVTX$2.5M75k sharesGrant / ExerciseJan 31, 2026$2.5M75k shares$33.10--
Travere Therapeutics, Inc.TVTX--120.2k sharesGrant / ExerciseJan 31, 2026Disclosure amount unavailable28.1k shares----
Travere Therapeutics, Inc.TVTX$3.2M92.1k sharesSellDec 1, 2025$700.2K20k shares$35.01--
Travere Therapeutics, Inc.TVTX$020k sharesGrant / ExerciseDec 1, 2025$324.6K20k shares$16.23--
Travere Therapeutics, Inc.TVTX$1.8M92.1k sharesSellSep 4, 2025$2.3K119 shares$19.71--
Travere Therapeutics, Inc.TVTX$1.7M92.2k sharesSellSep 3, 2025$8.3K454 shares$18.20--
Travere Therapeutics, Inc.TVTX$1.6M92.7k sharesSellAug 27, 2025$8.1K470 shares$17.31--
Travere Therapeutics, Inc.TVTX$2.0M93.1k sharesSellMay 5, 2025$37.6K1.8k shares$21.05--
Travere Therapeutics, Inc.TVTX--4.9k sharesGrant / ExerciseMay 2, 2025Disclosure amount unavailable4.9k shares----
Travere Therapeutics, Inc.TVTX$1.2M90k sharesSellApr 11, 2025$63148 shares$13.14--
Travere Therapeutics, Inc.TVTX$1.8M90k sharesSellFeb 3, 2025$104.5K5.2k shares$20.12--
Travere Therapeutics, Inc.TVTX$1.2M58k sharesGrant / ExerciseJan 31, 2025$1.2M58k shares$20.46--
Travere Therapeutics, Inc.TVTX--95.2k sharesGrant / ExerciseJan 31, 2025Disclosure amount unavailable21.5k shares----